Soleno Therapeutics
Redwood City
About Soleno Therapeutics
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $569.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nasdaq:SLNO
- Website: soleno.life
- Phone: (650) 213-8444
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/soleno-therapeutics-5547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.